NCT01006993View on ClinicalTrials.gov

Feasibility and Safety of NeuroFlo in Stroke Patients Receiving Tissue Plasminogen Activator

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

January 31, 2010

Conditions
Ischemic Stroke
Interventions
DEVICE

NeuroFlo catheter

NeuroFlo™ catheter 45 minute treatment

Trial Locations (4)

91054

University of Erlangen, Erlangen

T6G 2B7

University of Alberta, Edmonton

N6A 5A5

University of Western Ontario, London

L5B 4A2

Trillium Health Centre, Mississauga

Sponsors

Lead Sponsor

CoAxia
All Listed Sponsors
lead

CoAxia

INDUSTRY